SCHEMBL12808136

SCHEMBL12808136

CC1OC(COC(=O)c2ccccc2)C(F)C(OC(=O)c2ccccc2)C1OC(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LGALS9 O00182 1/20 0.42
LGALS1 P09382 1/20 0.42
LGALS3 P17931 1/20 0.42
LGALS7; LGALS7B P47929 1/20 0.42
PTPN1 P18031 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GAPDH P04406 1/20 0.40
LMNA P02545 2/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA5 P30532 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13274190 1.00 POLB (0.46) POLBMEN1USP2KMT2AALDH1A1
SCHEMBL20691411 0.96 POLB (0.47) POLBMEN1USP2KMT2AALDH1A1
SCHEMBL18871302 0.90 USP2 (0.55) POLBMEN1USP2KMT2AALDH1A1
SCHEMBL21754836 0.90 USP2 (0.55) POLBMEN1USP2KMT2AALDH1A1
SCHEMBL25506254 0.90 USP2 (0.55) POLBMEN1USP2KMT2AALDH1A1
SCHEMBL15759263 0.90 USP2 (0.55) POLBMEN1USP2KMT2AALDH1A1
SCHEMBL21754881 0.90 USP2 (0.55) POLBMEN1USP2KMT2AALDH1A1
SCHEMBL12300564 0.90 USP2 (0.55) POLBMEN1USP2KMT2AALDH1A1
SCHEMBL12222446 0.90 USP2 (0.55) POLBMEN1USP2KMT2AALDH1A1
SCHEMBL13873368 0.90 USP2 (0.55) POLBMEN1USP2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011039338-A2 USE OF COMPOUNDS WITH SGLT-1/SGLT-2 INHIBITOR ACTIVITY FOR PRODUCING MEDICAMENTS FOR TREATMENT OF BONE DISEASES SANOFI-AVENTIS (FR) 2011-04-07 WO disclosed